CNR Institutional Research Information System

PALMIERI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.750
NA - Nord America 7.528
EU - Europa 2.751
SA - Sud America 1.671
Continente sconosciuto - Info sul continente non disponibili 552
AF - Africa 178
OC - Oceania 13
Totale 22.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.171
SG - Singapore 3.844
CN - Cina 2.155
BR - Brasile 1.323
IT - Italia 1.264
HK - Hong Kong 946
VN - Vietnam 875
JP - Giappone 531
FR - Francia 515
KR - Corea 393
BD - Bangladesh 392
NL - Olanda 250
IN - India 166
CA - Canada 155
GB - Regno Unito 155
DE - Germania 127
AR - Argentina 98
CO - Colombia 80
FI - Finlandia 72
ID - Indonesia 72
IL - Israele 70
MX - Messico 67
EC - Ecuador 66
ZA - Sudafrica 53
IE - Irlanda 42
AT - Austria 41
SA - Arabia Saudita 41
TR - Turchia 36
IQ - Iraq 35
VE - Venezuela 35
PL - Polonia 34
PH - Filippine 31
UA - Ucraina 30
ES - Italia 27
RU - Federazione Russa 27
JM - Giamaica 26
MY - Malesia 26
CR - Costa Rica 24
MA - Marocco 24
PK - Pakistan 22
TN - Tunisia 20
KE - Kenya 19
SE - Svezia 19
GR - Grecia 18
PE - Perù 18
PY - Paraguay 18
UY - Uruguay 18
EG - Egitto 17
UZ - Uzbekistan 17
TT - Trinidad e Tobago 16
AE - Emirati Arabi Uniti 15
HN - Honduras 15
CZ - Repubblica Ceca 13
TH - Thailandia 12
NI - Nicaragua 11
PT - Portogallo 11
NP - Nepal 10
AL - Albania 9
BG - Bulgaria 9
CH - Svizzera 9
DZ - Algeria 9
NO - Norvegia 9
AU - Australia 8
BE - Belgio 8
CL - Cile 8
KZ - Kazakistan 8
LT - Lituania 8
SC - Seychelles 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
EE - Estonia 6
PR - Porto Rico 6
AZ - Azerbaigian 5
BO - Bolivia 5
HU - Ungheria 5
LV - Lettonia 5
OM - Oman 5
RO - Romania 5
RS - Serbia 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
CY - Cipro 4
DK - Danimarca 4
LK - Sri Lanka 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CU - Cuba 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
JO - Giordania 3
LB - Libano 3
LU - Lussemburgo 3
MM - Myanmar 3
PA - Panama 3
Totale 21.839
Salva come PNG Salva come JPEG
Città #
Singapore 2.249
Hefei 946
Hong Kong 938
San Jose 907
Santa Clara 774
Council Bluffs 668
Ashburn 504
Tokyo 467
Lauterbourg 410
Seoul 383
Ho Chi Minh City 310
Beijing 273
Hanoi 216
Dallas 200
Los Angeles 188
New York 185
Princeton 182
Abbeville 146
São Paulo 132
Rome 130
Milan 107
Naples 72
Buffalo 66
Minamishinagawa 56
Chicago 53
Boardman 51
Helsinki 50
Frankfurt am Main 46
Phoenix 46
Cagliari 45
Cavallino 44
Genoa 42
Rio de Janeiro 42
Atlanta 39
Houston 39
Montreal 39
Orem 39
Brooklyn 38
Guangzhou 38
Bengaluru 37
Da Nang 37
Dublin 36
Toronto 35
Philadelphia 33
Brasília 32
Haiphong 32
Johannesburg 32
Amsterdam 31
Vienna 31
Belo Horizonte 30
Florence 30
Charlotte 28
Turin 27
Porto Alegre 26
Dhaka 25
Manchester 25
Bari 24
Curitiba 23
Denver 23
London 23
Miami 23
Quito 23
San Gregorio di Catania 23
Salvador 22
Bogotá 21
Jacksonville 21
Nuremberg 21
Las Vegas 20
The Bronx 20
Warsaw 20
Chennai 19
Detroit 19
Guayaquil 19
Hải Dương 19
Mumbai 19
Riyadh 19
Bologna 18
Catania 18
Paris 18
Queens 18
Sassari 18
Stockholm 18
Campinas 17
Palermo 17
San José 17
Boston 16
Kingston 16
Memphis 16
Newark 16
Washington 16
Düsseldorf 15
Montevideo 15
Nairobi 15
Tashkent 15
Jakarta 14
Sala Baganza 14
San Francisco 14
Seattle 14
Shanghai 14
St Louis 14
Totale 12.491
Salva come PNG Salva come JPEG
Nome #
Parental use and educational campaigns on sunbed use among teenagers and adolescents 236
Idiopathic pulmonary fibrosis (IPF) and lung cancer 187
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 131
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 125
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 98
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 96
Second primary melanoma on a patient undergoing vemurafenib therapy. A case report. 95
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 94
Antitumoral effects of Vanadium compounds in malignant melanoma cell lines 93
Anti- and Pro-Oxidant Activity of Polyphenols Extracts of Syrah and Chardonnay Grapevine Pomaces on Melanoma Cancer Cells 92
Il CSCC: aspetti distintivi della patologia 90
Germline and somatic NGS-based analysis on BRCA-related tumors 88
ANTIPROLIFERATIVE ACTIVITY OF VANADIUM COMPOUNDS: EFFECTS ON THE MAJOR MALIGNANT MELANOMA MOLECULAR PATHWAYS 87
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 86
Analisi di mutazioni somatiche e germinali in geni candidati 85
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 85
Iodinated 4,4’‐bipyridines with antiproliferative activity against melanoma cell lines 85
The role of NEMO (NF-kB essential modulator) binding domain (NDB) peptide in inducing apoptosis in A375 melanoma cell line. 84
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 84
Stable integration and expression in mouse cells of yeast artificial chromosomes harboring human genes. 83
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 81
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 81
A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration 81
Pancreatic cancer burden in North Sardinia, Italy 81
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe (R) Panel 81
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 80
Construction of a pilot YAC library in a recombinant-defective yeast strain 79
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 79
Attività anti-proliferativa e pro-apoptotica di bifenili derivati dall eugenolo e dall isoeugenolo su cellule tumorali di melanoma maligno. 77
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 77
Liquid biopsy in clinical oncology 76
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 76
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 75
Exploring interaction modes between polysaccharide-based selectors and biologically active 4,4'-bipyridines by experimental and computational analysis 75
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 75
What is changing in the adjuvant treatment of melanoma? 74
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 74
Phenotype characterization of human melanoma cells resistant to Dabrafenib 74
Metronomic schedale of temozollomide with conventional dose of cisplatin in metastatic melanoma. 73
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 72
Analisi mutazionali nei pazienti con tumori solidi 72
COLORECTAL CANCER EPIDEMIOLOGY IN AN AREA WITH A SPONTANEOUS SCREENING PROGRAM 72
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 72
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 72
Molecular landscape profile of melanoma 72
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 71
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 71
Current Trends in Mucosal Melanomas: An Overview 71
nalysis of Fanconi anemia genes in colorectal cancer. 70
Genetic Instability Markers in Cancer 70
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 70
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 70
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 70
Nanotecnologie Applicate alla classificazione MOlecolare delle MAlattie Complesse (NaMoMaC) 69
Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: a pilot study. 68
Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L 68
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 67
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 67
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 67
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 66
PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis 66
The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 65
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 65
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. 64
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the "Melanoma Research: A bridge from Naples to the World. Napoli, December 5 th-6 th2011" 64
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. 64
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 62
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 62
Screening genetico-molecolare del carcinoma della mammella e del cancro del colon-retto nel Nord Sardegna 61
Analoghi strutturali della curcumina come potenziali agenti antitumorali contro il melanoma maligno. 61
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 61
Molecular classification of patients with malignant melanoma for new therapeutic strategies. 60
Adjuvant treatment of malignant melanoma: Where are we? 59
In vitro and in vivo evaluation of the antitumour activity for a new curcumin-related compound in melanoma and neuroblastoma cells 59
Prevalence of BRCA1 and BRCA2 mutations in Sardinia. 59
AhR (Aryl Hydrocarbon Receptor) Polymorphisms: A Possible Role in TCDD (Dioxins)-AhR Binding and Carcinogenesis 59
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 59
Adjuvant therapy of cutaneous melanoma. 58
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 58
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 58
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 58
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 57
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy) 57
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 57
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 56
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 56
Epithelioid cell-type melanoma as a prognostic factor of poor response to immunological treatment. 55
Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines 55
Dioxin contamination in food chain: food and dioxins. 55
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 55
Ngs-based analysis of atypical deep penetrating nevi 55
The enigmatic role of TP53 in germ cell tumours: Are we missing something? 55
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with ad-vanced melanoma treated with nivolumab 55
Reproductive aging-associated common genetic variants and the risk of breast cancer. 55
Studio epidemiologico sull'incidenza dei tumori nei lavoratori e nella popolazione della zona industriale di Porto Torres 54
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 54
Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis 54
A CXCR4 point mutation (G574A) detected in human cancer cell lines impaired tumor growth and affected ADM3100 sensitivity. 54
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 54
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in mela-noma treatment 54
Totale 7.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.773
article - articoli 58.436
book - libri 323
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.865
Totale 137.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202491 0 0 0 0 0 0 0 0 7 4 33 47
2024/20255.442 44 23 389 296 764 159 81 196 148 233 1.646 1.463
2025/202612.388 562 992 1.107 1.515 1.639 407 2.005 1.191 950 952 529 539
2026/20274.522 625 802 1.635 1.460 0 0 0 0 0 0 0 0
Totale 22.443